Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823328 · ClinicalTrials.gov registry record · Phase 4
Ketamine Versus Etomidate for Rapid Sequence Intubation
A Phase 4 study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 143
- Enrollment target
NCT01823328 is a Phase 4 study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 143 participants.
The verdict
NCT01823328, a Phase 4 study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 143 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).
Interventions
- DRUG Ketamine
- DRUG Etomidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823328
The ClinicalTrials.gov registry entry for NCT01823328 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT01823328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01823328 about?
NCT01823328 is a clinical study titled "Ketamine Versus Etomidate for Rapid Sequence Intubation". The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).
What is the current status of trial NCT01823328?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 143 participants. The study started on 2013-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01823328?
The interventions under investigation include: Ketamine (DRUG), Etomidate (DRUG).
Who is sponsoring clinical trial NCT01823328?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.